Parathyroid Hormone as a Drug Target and Biomarker: A Journey to Unraveling its Potential Therapies

Target Name: PTH

NCBI ID: G5741

Content of Review Report on PTH Target / Biomarker

PTH

Parathyroid Hormone as a Drug Target and Biomarker: A Journey to Unraveling its Potential Therapies

Parathyroid hormone (PTH) is a pleiotropic hormone that plays a crucial role in maintaining homeostasis, regulating bone growth, and promoting calcium homeostasis. Produced by the parathyroid gland, PTH is essential for maintaining the proper levels of calcium in the blood, which is crucial for various physiological functions, including muscle contractions, nerve function, and blood clotting. PTH has also been implicated in the regulation of bone mass and density, as well as cardiovascular and respiratory function.

Despite its importance, the parathyroid gland is often targeted by medications for the treatment of various diseases, including hyperparathyroidism, hypoparathyroidism, and hyperkalemia. However, the exact mechanism of action of these treatments is not well understood.

As a drug target, PTH has the potential to be a therapy for various diseases, including bone and muscle diseases, as well as cardiovascular and respiratory disorders. In this article, we will explore the potential of PTH as a drug target and biomarker, and discuss its current and future clinical applications.

PTH as a Drug Target

PTH has been shown to play a role in the regulation of various physiological processes in the body, including bone growth and maintenance, blood calcium levels, and muscle function. Its effects on these processes make PTH an attractive target for the development of new therapies.

One of the most well-known drug targets for PTH is its role in bone growth and maintenance. PTH has been shown to increase bone density in both humans and animals, and has been used in the treatment of osteoporosis and bone fractures.

In addition to its effects on bone growth and maintenance, PTH has also been shown to play a role in the regulation of blood calcium levels. Hyperparathyroidism, a condition in which the parathyroid gland produces too much PTH, can lead to an excess of calcium in the blood, which can cause a variety of symptoms, including muscle weakness, nerve symptoms, and heart arrhythmias. PTH has been shown to be a potential therapeutic for this condition, as it has been shown to reduce the levels of calcium in the blood in individuals with hyperparathyroidism.

Another potential drug target for PTH is its role in muscle function. PTH has been shown to regulate muscle contractions and has been used in the treatment of muscle-wasting diseases, such as cachexia and wasting disorders.

PTH has also been shown to play a role in the regulation of cardiovascular and respiratory function. It has been shown to increase contractility in blood vessels, which can improve blood flow and reduce the risk of cardiovascular disease. In addition, PTH has been shown to regulate the production of white blood cells in the bone marrow, which are responsible for immune function.

PTH as a Biomarker

PTH has also been shown to be a potential biomarker for various diseases, including bone and muscle diseases, cardiovascular and respiratory disorders, and neurodegenerative diseases.

One of the most promising applications of PTH as a biomarker is its potential to diagnose and monitor the progression of bone and muscle diseases, such as osteoporosis and muscle-wasting disorders. PTH has been shown to be decreased in individuals with osteoporosis, and may be a useful biomarker for diagnosing this condition. Similarly, PTH has been shown to be decreased in individuals with muscle-wasting disorders, and may be a useful biomarker for diagnosing and monitoring the progression of this condition.

In addition to its potential as a diagnostic biomarker, PTH has also been shown to be involved in the regulation of various physiological processes in the body, including blood calcium levels, muscle function, and cardiovascular and respiratory function. These factors make PTH an

Protein Name: Parathyroid Hormone

Functions: PTH elevates calcium level by dissolving the salts in bone and preventing their renal excretion. Stimulates [1-14C]-2-deoxy-D-glucose (2DG) transport and glycogen synthesis in osteoblastic cells

The "PTH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PTH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets